---
title: "BeOne Medicines Ltd (6160) Gets a Buy from CICC"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295286738.md"
description: "CICC maintained a Buy rating on BeOne Medicines Ltd (6160) with a HK$266 price target, while Bank of America Securities also issued a Buy rating with a HK$255.43 target. The stock closed at HK$199.50. Analyst consensus suggests a Strong Buy with an average target of HK$268.65, indicating significant upside potential."
datetime: "2026-08-08T00:35:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295286738.md)
  - [en](https://longbridge.com/en/news/295286738.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295286738.md)
generator: "portal-rs"
---

# BeOne Medicines Ltd (6160) Gets a Buy from CICC

In a report released on August 6, from CICC maintained a Buy rating on BeOne Medicines Ltd, with a price target of HK$266.00. The company’s shares closed yesterday at HK$199.50.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

The word on The Street in general, suggests a Strong Buy analyst consensus rating for BeOne Medicines Ltd with a HK$268.65 average price target, a 34.66% upside from current levels. In a report released on August 6, Bank of America Securities also maintained a Buy rating on the stock with a HK$255.43 price target.

### Related Stocks

- [BGNE.US](https://longbridge.com/en/quote/BGNE.US.md)
- [06160.HK](https://longbridge.com/en/quote/06160.HK.md)
- [688235.CN](https://longbridge.com/en/quote/688235.CN.md)
- [ONC.US](https://longbridge.com/en/quote/ONC.US.md)
- [03908.HK](https://longbridge.com/en/quote/03908.HK.md)
- [601995.CN](https://longbridge.com/en/quote/601995.CN.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)

## Related News & Research

- [BeOne Medicines and partners renew Brukinsa access programme for CLL](https://longbridge.com/en/news/296331290.md)
- [Bank of China Sticks to Their Buy Rating for BeOne Medicines Ltd (6160)](https://longbridge.com/en/news/285667787.md)
- [Telsey Advisory Reaffirms Their Buy Rating on TJX Companies (TJX)](https://longbridge.com/en/news/296370224.md)
- [12:05 ETD.Law Launches "The Champion," a New Newsletter Dedicated to Educating California Workers on Their Rights](https://longbridge.com/en/news/296379439.md)
- [3 Low-Cost ETFs For Investors Seeking to Check Out Walmart Ahead of Q2 Earnings – GXPS, FSTA,TRUO.](https://longbridge.com/en/news/296381462.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**